Submission for OMB Review; 30-Day Comment Request: Request for Human Embryonic Stem Cell Line To Be Approved for Use in NIH Funded Research (Office of the Director), 35401-35402 [2019-15659]
Download as PDF
<![CDATA[
35401
Federal Register / Vol. 84, No. 141 / Tuesday, July 23, 2019 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: July 17, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
Dated: July 16, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–15568 Filed 7–22–19; 8:45 am]
[FR Doc. 2019–15567 Filed 7–22–19; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Submission for OMB Review; 30-Day
Comment Request: Request for Human
Embryonic Stem Cell Line To Be
Approved for Use in NIH Funded
Research (Office of the Director)
any additional information for the meeting
will be posted when available.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Impaired
Wound Healing in Aging.
Date: August 9, 2019.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call)
Contact Person: Inese Z Beitins, MD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health,6701 Rockledge Drive, Room 6152,
MSC 7892, Bethesda, MD 20892, 301–435–
1034, beitinsi@csr.nih.gov.
AGENCY:
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Dr. Ellen Gadbois,
Office of the Director, NIH, Building 1,
Room 218, MSC 0166, 9000 Rockville
Pike, Bethesda, MD 20892, or call nontoll-free number (301) 496–9838 or
email your request, including your
address to: gadboisel@od.nih.gov.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on May 16, 2019, page 22153
(84 FR 22153) and allowed 60 days for
public comment. No public comments
were received. The purpose of this
notice is to allow an additional 30 days
for public comment. The NIH Office of
the Director may not conduct or
sponsor, and the respondent is not
required to respond to, an information
collection that has been extended,
revised, or implemented on or after
October 1, 1995, unless it displays a
currently valid OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: Request for
Human Embryonic Stem Cell Line to be
approved for Use in NIH Funded
Research. OMB No. 0925–0601—
Extension—Expiration Date 07/31/
2019—Office of the Director, National
Institutes of Health (NIH).
Need and Use of Information
Collection: The form is used by
applicants to request that human
embryonic stem cell lines be approved
for use in NIH funded research.
Applicants may submit applications at
any time.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
255 per respondent.
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
SUMMARY:
Written comments and/or
suggestions regarding the item(s)
contained in this notice, especially
regarding the estimated public burden
and associated response time, should be
directed to the: Office of Management
and Budget, Office of Regulatory Affairs,
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974, Attention: Desk
Officer for NIH.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
ADDRESSES:
ESTIMATED ANNUALIZED BURDEN HOURS
jspears on DSK30JT082PROD with NOTICES
Number of
responses per
respondent
Number of
respondents
Type of respondent
Average time
per response
(in hours)
Total annual
burden hours
NIH grantees and others with hESC lines .......................................................
5
3
17
255
Total ..........................................................................................................
........................
15
........................
255
VerDate Sep<11>2014
16:43 Jul 22, 2019
Jkt 247001
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
E:\FR\FM\23JYN1.SGM
23JYN1
35402
Federal Register / Vol. 84, No. 141 / Tuesday, July 23, 2019 / Notices
Dated: July 17, 2019.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
[FR Doc. 2019–15659 Filed 7–22–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
jspears on DSK30JT082PROD with NOTICES
Office of the Director, National
Institutes of Health Notice of Meeting
Notice is hereby given of a meeting of
the HEAL (Helping to End Addiction
Long-term) Multi-Disciplinary Working
Group.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended.
The program documents and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the program
documents, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: HEAL MultiDisciplinary Working Group Meeting.
Date: August 21–22, 2019.
Open: August 21, 2019, 8:30 a.m. to
1:00 p.m.
Closed: August 21, 2019, 1:00 p.m. to
5:00 p.m.
Open: August 22, 2019, 8:30 a.m. to
11:30 a.m.
Closed: August 22, 2019, 11:30 a.m. to
3:30 p.m.
Agenda: Provide an update on
Helping to End Addiction Long-Term
(HEAL) Initiatives projects and obtain
expertise from MDWG relevant to the
NIH HEAL Initiative.
Videocast: For those not able to attend
in person, this meeting will be live
webcast at: https://videocast.nih.gov/.
Place: National Institutes of Health,
Building 1, Wilson Hall, 1 Center Drive,
Bethesda, MD 20892.
Contact Person: Rebecca G. Baker,
Ph.D., Office of the Director, National
Institutes of Health, 1 Center Drive,
Room 103A, Bethesda, MD 20892, (301)
402–1994, Rebecca.baker@nih.gov.
VerDate Sep<11>2014
16:43 Jul 22, 2019
Jkt 247001
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for
entrance onto the NIH campus. All
visitors must go through a security
check at the building entrance to receive
a visitor’s badge. All visitor vehicles,
including taxicabs, hotel, and airport
shuttles will be inspected before being
allowed on campus. Visitors will be
asked to show one form of identification
(for example, a government-issued
photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the
Office of the Director for the NIH HEAL
Initiative home page: https://
www.nih.gov/research-training/medicalresearch-initiatives/heal-initiative
where an agenda and any additional
information for the meeting will be
posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: July 16, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–15569 Filed 7–22–19; 8:45 am]
BILLING CODE 4140–01–P
Name of Committee: Office of Research
Infrastructure Programs Special Emphasis
Panel Member Conflict: Scientific and
Technical Review Board on Biomedical and
Behavioral Research Facilities.
Date: July 25, 2019.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Craig Giroux, Ph.D.,
Scientific Review Officer, BST IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5150,
Bethesda, MD 20892, 301–435–2204,
girouxcn@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: July 17, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–15571 Filed 7–22–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended.
The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
Office of the Director, National
Institutes of Health Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Office of Research
Infrastructure Programs Special Emphasis
Panel; Conferences and Meetings: Office of
Research Infrastructure Programs (ORIP).
E:\FR\FM\23JYN1.SGM
23JYN1
]]>Agencies
[Federal Register Volume 84, Number 141 (Tuesday, July 23, 2019)]
[Notices]
[Pages 35401-35402]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-15659]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request: Request for
Human Embryonic Stem Cell Line To Be Approved for Use in NIH Funded
Research (Office of the Director)
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has submitted to the Office of
Management and Budget (OMB) a request for review and approval of the
information collection listed below.
DATES: Comments regarding this information collection are best assured
of having their full effect if received within 30-days of the date of
this publication.
ADDRESSES: Written comments and/or suggestions regarding the item(s)
contained in this notice, especially regarding the estimated public
burden and associated response time, should be directed to the: Office
of Management and Budget, Office of Regulatory Affairs,
[email protected] or by fax to 202-395-6974, Attention: Desk
Officer for NIH.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact: Dr. Ellen Gadbois, Office of the Director, NIH,
Building 1, Room 218, MSC 0166, 9000 Rockville Pike, Bethesda, MD
20892, or call non-toll-free number (301) 496-9838 or email your
request, including your address to: [email protected].
SUPPLEMENTARY INFORMATION: This proposed information collection was
previously published in the Federal Register on May 16, 2019, page
22153 (84 FR 22153) and allowed 60 days for public comment. No public
comments were received. The purpose of this notice is to allow an
additional 30 days for public comment. The NIH Office of the Director
may not conduct or sponsor, and the respondent is not required to
respond to, an information collection that has been extended, revised,
or implemented on or after October 1, 1995, unless it displays a
currently valid OMB control number.
In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction
Act of 1995, the National Institutes of Health (NIH) has submitted to
the Office of Management and Budget (OMB) a request for review and
approval of the information collection listed below.
Proposed Collection: Request for Human Embryonic Stem Cell Line to
be approved for Use in NIH Funded Research. OMB No. 0925-0601--
Extension--Expiration Date 07/31/2019--Office of the Director, National
Institutes of Health (NIH).
Need and Use of Information Collection: The form is used by
applicants to request that human embryonic stem cell lines be approved
for use in NIH funded research. Applicants may submit applications at
any time.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 255 per respondent.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average time
Type of respondent Number of responses per per response Total annual
respondents respondent (in hours) burden hours
----------------------------------------------------------------------------------------------------------------
NIH grantees and others with hESC lines......... 5 3 17 255
---------------------------------------------------------------
Total....................................... .............. 15 .............. 255
----------------------------------------------------------------------------------------------------------------
[[Page 35402]]
Dated: July 17, 2019.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2019-15659 Filed 7-22-19; 8:45 am]
BILLING CODE 4140-01-P
